Our research strategy explores how the priority of the Grace Kelly Childhood Cancer Trust is to fund projects with clear translatable outcomes that are most likely to lead to an improvement in treatment in the relatively near future.


The GKCCT is working to fund world-class research into rare aggressive childhood cancers including rhabdoid and other rare aggressive cancers.

We wish to concentrate on the earlier diagnosis and treatment of rare cancers, working towards looking for kinder and more effective treatments for these cancers which currently have poor prognoses.

To read full details of our research strategy, please see the link below:

Our Research Strategy

Research Code of Conduct

Research Conflicts of Interests